- Home
- SILA vs TXG Comparison
SILA vs TXG Comparison
Compare SILA & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILA
- TXG
- Stock Information
- Founded
- SILA 2013
- TXG 2012
- Country
- SILA United States
- TXG United States
- Employees
- SILA N/A
- TXG N/A
- Industry
- SILA
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- SILA
- TXG Industrials
- Exchange
- SILA NYSE
- TXG Nasdaq
- Market Cap
- SILA 1.4B
- TXG 1.3B
- IPO Year
- SILA N/A
- TXG 2019
- Fundamental
- Price
- SILA $24.30
- TXG $11.70
- Analyst Decision
- SILA Strong Buy
- TXG Buy
- Analyst Count
- SILA 3
- TXG 14
- Target Price
- SILA $28.67
- TXG $14.96
- AVG Volume (30 Days)
- SILA 365.7K
- TXG 4.1M
- Earning Date
- SILA 08-05-2025
- TXG 08-07-2025
- Dividend Yield
- SILA 6.60%
- TXG N/A
- EPS Growth
- SILA 45.68
- TXG N/A
- EPS
- SILA 0.63
- TXG N/A
- Revenue
- SILA $184,473,000.00
- TXG $624,662,000.00
- Revenue This Year
- SILA $7.93
- TXG N/A
- Revenue Next Year
- SILA $9.13
- TXG $6.06
- P/E Ratio
- SILA $38.58
- TXG N/A
- Revenue Growth
- SILA N/A
- TXG N/A
- 52 Week Low
- SILA $20.30
- TXG $6.78
- 52 Week High
- SILA $27.50
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- SILA N/A
- TXG 69.72
- Support Level
- SILA N/A
- TXG $10.63
- Resistance Level
- SILA N/A
- TXG $11.10
- Average True Range (ATR)
- SILA 0.00
- TXG 0.64
- MACD
- SILA 0.00
- TXG 0.11
- Stochastic Oscillator
- SILA 0.00
- TXG 85.86
About SILA SILA REALTY TRUST INC
Sila Realty Trust Inc is a real estate investment trust. Its investment objective is to pay regular cash distributions to stockholders and to preserve, protect, and return capital contributions to stockholders. The company owns and manages healthcare assets. The company generates revenue from real estate investments in healthcare properties.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).